CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected Female sex workers
<p>Abstract</p> <p>Background</p> <p>Design of effective vaccines against the human immunodeficiency virus (HIV-1) continues to present formidable challenges. However, individuals who are exposed HIV-1 but do not get infected may reveal correlates of protection that may...
Main Authors: | Meyers Adrienne FA, Matey Elizabeth J, Apidi Winnie, Rono Martin K, Mckinnon Lyle, Osero Bernard, Songok Elijah M, Luo Ma, Kimani Joshua, Wachihi Charles, Ball Blake T, Plummer Frank A, Mpoke Solomon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/7/1/343 |
Similar Items
-
Regulation of chemokine activity – a focus on the role of dipeptidyl peptidase IV/CD26
by: Mieke Metzemaekers, et al.
Published: (2016-11-01) -
CD26/dipeptidyl peptidase IV contributes to tumor metastasis in human lung adenocarcinoma
by: Lei Liu, et al.
Published: (2013-05-01) -
Mapping Salivary Proteases in Sjögren’s Syndrome Patients Reveals Overexpression of Dipeptidyl Peptidase-4/CD26
by: Laís Garreto, et al.
Published: (2021-06-01) -
Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
by: Aline Beckenkamp, et al.
Published: (2015-01-01) -
Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.
by: Mary A Fletcher, et al.
Published: (2010-05-01)